Allet B, Bernard A R, Hochmann A, Rohrbach E, Graber P, Magnenat E, Mazzei G J, Bernasconi L
Geneva Biomedical Research Institute, Glaxo-Wellcome Research and Development S.A., Switzerland.
Protein Expr Purif. 1997 Feb;9(1):61-8. doi: 10.1006/prep.1996.0675.
Escherichia coli remains an organism of choice for the production of recombinant proteins required in large quantities. Whenever possible, secretion is the preferred strategy since it permits easy and efficient purification from the extracellular medium. Our efforts to use E. coli to secrete a human CD23 soluble variant fused to a pair of IgG binding domains via the Staphylococcal protein A signal peptide were unsuccessful. Surprisingly, when the same construct was expressed in the baculovirus system, efficient secretion was observed and cleavage of the signal peptide occurred at the expected site. Varying the genes in the fusions or the tags, or the topology of the gene and the tag, did not affect the high-level secretion and cleavage at the correct site. We envision that fusion of the bacterial signal sequence to eukaryotic recombinant genes will prove to be a tool of value for efficient protein secretion in insect cells using the baculovirus expression system.
大肠杆菌仍然是大量生产所需重组蛋白的首选生物体。只要有可能,分泌就是首选策略,因为它允许从细胞外培养基中轻松有效地纯化。我们尝试利用大肠杆菌通过葡萄球菌蛋白A信号肽分泌与一对IgG结合域融合的人CD23可溶性变体,但未成功。令人惊讶的是,当相同构建体在杆状病毒系统中表达时,观察到了高效分泌,并且信号肽在预期位点发生了切割。改变融合基因或标签中的基因,或者基因和标签的拓扑结构,并不影响在正确位点的高水平分泌和切割。我们设想,将细菌信号序列与真核重组基因融合将被证明是一种有价值的工具,可用于利用杆状病毒表达系统在昆虫细胞中高效分泌蛋白质。